VIZENDO

What this record means

The record shows that “VIZENDO” is a cancelled Principal Register trademark owned by Glaxo Group Limited; the registration was cancelled on Jan 30 2015 because the owner failed to file an acceptable Section 8 declaration, and the record contains no later activity. The registration covered Class 005 pharmaceuticals, specifically “pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia and obesity, and for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmological, respiratory, neurological, gastrointestinal, hormonal, dermatological and psychiatric related diseases and disorders, and for the treatment of damaged skin and tissue; and for vaccines.” A similar name used for drugs or medical treatments would raise the closest record‑based concern, while uses outside that therapeutic scope are farther from the listed area. The record does not give Glaxo control over every possible use of the word “Vizendo.” No oppositions, cancellations beyond the Section 8 event, or court actions appear, so the supplied history shows no visible enforcement activity. I'd treat this as a meaningful concern if you plan a pharma‑related brand, but the risk is lower for unrelated goods or services.